3′-deoxy nucleosides for the treatment of HCV

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9309275
APP PUB NO 20140248241A1
SERIAL NO

14195388

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are compounds, compositions and methods for the treatment of Flaviviridae infections, including HCV infections. In certain embodiments, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in combination with other anti-viral agents. In certain embodiments, the compounds are 3′-deoxy nucleoside compounds according to Formula 3001a or 3001b:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IDENIX PHARMACEUTICALS LLC320 BENT STREET CAMBRIDGE MA 02141

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alexandre, Francois-Rene Montpellier, FR 29 506
Dukhan, David Saint Gely du Fesc, FR 40 749
Gosselin, Gilles Montpellier, FR 98 3486
Mayes, Benjamin Alexander Boston, US 29 780
Moussa, Adel M Burlington, US 51 897
Parsy, Christophe Claude Jacou, FR 31 549
Pierra, Claire Montarnaud, FR 24 834
Stewart, Alistair James Lincoln, US 20 461
Surleraux, Dominique Wauthier-Braine, BE 35 756

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 12, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00